A new double-blind, placebo-controlled crossover study has found that cannabidiol (CBD) led to behavioral improvements in about two-thirds of boys with autism spectrum disorder, though researchers emphasize that a strong placebo effect complicates interpretation of the results. Conducted by the University of California San Diego School of Medicine and published in the Journal of Autism …
Category: News
May 23 2025
Study: CBD May Delay and Reduce Symptoms of Parkinson’s Disease
A new study published in the journal Frontiers in Pharmacology has found that cannabidiol (CBD) may help delay the onset and reduce the severity of Parkinson’s-like symptoms, particularly when administered as a preventive treatment. Conducted by researchers from Universidade Federal de São Paulo, Universidade de São Paulo, and Brazil’s National Council for Scientific and Technological …
May 23 2025
Canada’s Legal Marijuana Market Generated CA$428.4 Million in Sales in March, Pushing Q1 Total to CA$1.27 Billion
Canada’s legal marijuana market generated CA$428.4 million in sales in March, according to newly released data from Statistics Canada. The March total marks an increase from February’s CA$404.7 million, though it still falls short of January’s CA$437 million. Combined, legal marijuana sales in the first quarter of 2025 now total approximately CA$1.27 billion. Ontario once …
May 22 2025
Massachusetts Bill to Ban Job Discrimination for Legal Marijuana Use Set for Public Hearing June 10
Legislation that would prohibit employers in Massachusetts from discriminating against workers or applicants based solely on their legal marijuana use is scheduled for a public hearing on June 10 in the Joint Committee on Labor and Workforce Development. House Bill 2179 was introduced in February by State Representative Chynah Tyler (D). It would amend state …
May 22 2025
Study: Cannabis Legalization in Canada Linked to Far Fewer Hospitalizations Among Youth
A study published today by the American Journal of Public Health finds that Canada’s legalization of marijuana was associated with a sharp decline in cannabis-related hospitalizations among youth under the minimum legal age (MLA), suggesting age restrictions may help protect young people. Researchers from the University of Ottawa, University of Southern California, University of Toronto, and …
May 22 2025
New Hampshire Senate Schedules Psilocybin Decriminalization Bill for June 5 Vote
The New Hampshire Senate has scheduled a vote on legislation to decriminalize psilocybin for June 5. If House Bill 528 is given approval by the full Senate, it will first return to the House for a concurrence vote on Senate amendments before being sent to Governor Kelly Ayotte. Sponsored by State Representative Kevin Verville (R), …
May 22 2025
New York Senate Approves Medical Marijuana Reciprocity Bill
The New York Senate has advanced legislation that would expand the state’s medical marijuana program by allowing out-of-state patients to access dispensaries and by allowing the sale of pre-rolled marijuana products. Senate Bill 3105, sponsored by State Senator Jeremy Cooney, received passage today through its second reading in the full Senate. The measure amends the …
May 22 2025
Nanoencapsulated CBD May Reduce Panic-Like Responses, Finds Study
A study published today by the International Journal of Pharmaceutics finds that nanoencapsulated cannabidiol (CBD) may significantly reduce panic-like behaviors. Researchers from the University of São Paulo, the Federal University of Rio Grande do Sul, and the University of Poonch Rawalakot explored how nanoencapsulation—specifically, polymeric lipid core-based technology—affects CBD’s impact on defensive behaviors triggered by exposure …
May 22 2025
Study: Low-Dose CBD Reverses Depression-Like Effects of Chronic Stress in Animal Model
A new study published in Neuropharmacology has found that an ultra-low dose of cannabidiol (CBD) may effectively reverse some of the behavioral and molecular effects of chronic stress, a major factor contributing to depression. Researchers from the University of Barcelona and the University of Greifswald administered a low dose of CBD (1 mg/kg) to mice …
May 22 2025
Study: CBD and Green Tea Compound EGCG Show Synergistic Inhibition of COVID-19 Virus in Lab Tests
A new peer-reviewed study published in the journal Virology finds that cannabidiol (CBD) and a green tea-derived compound may work together to inhibit the virus responsible for COVID-19. Conducted by researchers at Harbin Medical University in China and the University of Calgary in Canada, the study examined the effects of several natural polyphenolic compounds—CBD, green …